Genetic Information Nondiscrimination Act (GINA)

The Genetic Information Nondiscrimination Act (GINA) is a landmark U.S. federal law enacted in 2008 to protect individuals from the misuse of their genetic information. The law defines "genetic information" broadly to include an individual's genetic test results, the genetic test results of family members, and the manifestation of a disease or disorder in family members (i.e., family medical history). It also covers requests for, or receipt of, genetic services or participation in clinical research that includes genetic services.

GINA is divided into two main sections. Title I prohibits group and individual health insurers from using a person's genetic information to determine eligibility, calculate premiums, or decide on coverage. Insurers are also forbidden from requiring or requesting that an individual undergo a genetic test. Title II makes it illegal for employers with 15 or more employees to use genetic information in decisions about hiring, firing, promotion, or any other term or condition of employment. It also strictly limits an employer's ability to request, require, or purchase genetic information about an employee or their family members.

GINA was passed in response to rapid advances in genetics and genomics, particularly the completion of the Human Genome Project in 2003. As genetic testing became more accessible and affordable, concerns grew among the public, scientists, and policymakers that this sensitive information could be used to discriminate against individuals who were healthy but had a genetic predisposition to a future illness. Lawmakers feared that without legal protections, people would be reluctant to undergo genetic testing for clinical care or participate in genetic research, thereby hindering medical progress. GINA was designed to alleviate these fears and encourage the responsible use of genetic technologies in healthcare and research.

For patients and the public, GINA provides a crucial baseline of protection that allows them to make decisions about their health without fear of reprisal from insurers or employers. It empowers individuals to utilize predictive genetic testing for conditions like hereditary cancers (e.g., BRCA mutations) or Huntington's disease, enabling proactive medical care and family planning. However, it is important to understand GINA's limitations. The law does not protect against genetic discrimination in other forms of insurance, such as life, disability, or long-term care insurance. It also does not apply to employers with fewer than 15 employees, the U.S. military, or the federal government's TRICARE military health system and Federal Employees Health Benefits Program, though these are covered by separate policies.